Document Type within your search.
Document Type within your search.
1
Mangiapia, G.
2012
2012
Biomaterials, 33 (2012) S. 3770 - 3782
“...MeSH Antineoplastic Agents: administration & dosage...”
2
Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide
Stuplich, M.
2012
2012
Journal of clinical oncology, 30 (2012) S. e180 - 183
“...MeSH Antineoplastic Agents, Alkylating: administration & dosage...”
3
Haenisch, B.
2011
2011
Leukemia research, 35 (2011) S. 1248 - 1253
“...MeSH Antineoplastic Agents: pharmacology...”
4
Piroth, M.D.
2011
2011
Radiotherapy and oncology, 99 (2011) S. 218 - 224
“...MeSH Antineoplastic Agents, Alkylating: therapeutic use...”
5
Piroth, M.D.
2011
2011
International journal of radiation oncology, biology, physics, 80 (2011) S. 176 - 184
“...MeSH Antineoplastic Agents, Alkylating: therapeutic use...”
6
Kumar, A.
2010
2010
Angewandte Chemie / International edition, 49 (2010) S. 7504-7507
“...MeSH Antineoplastic Agents: isolation & purification...”
7
Kronenberg, T.
2010
2010
Wirtschafts- und sozialstatistisches Archiv, 4 (2010) S. 223 - 248
“...MeSH Antineoplastic Agents: adverse effects...”
8